The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Marcus Schmidt
No relevant relationships to disclose
Leonie van de Sandt
No relevant relationships to disclose
Karolina Edlund
No relevant relationships to disclose
Isabel Sicking
No relevant relationships to disclose
Marco Johannes Battista
No relevant relationships to disclose
Antje Lebrecht
No relevant relationships to disclose
Gerald Hoffmann
No relevant relationships to disclose
Joerg Rahnenfuehrer
No relevant relationships to disclose
Jan G Hengstler
No relevant relationships to disclose